"Designing Growth Strategies is in our DNA"

U.S. Substance Use Disorder Treatment Market Size, Share & COVID-19 Impact, By Level of Care (Early Intervention, Level 1/Outpatient Services, Level 2, Level 3, and Level 4/Medically Managed Intensive Inpatient Services), By Application (Alcohol Addiction Treatment, Drug Abuse Treatment, Nicotine Addiction Treatment, and Opioid Addiction Treatment), By Age Group (Adult and Adolescent), By Service Provider (Rehabilitation Centers, Hospitals and Specialty Clinics, Sober Living Homes, and Others), and Forecasts, 2022-2029

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI107172

 


To get information on various segments, share your queries with us

 

  ATTRIBUTE

  DETAILS

Study Period

2018-2029

Base Year

2021

Estimated Year

2022

Forecast Period

2022-2029

Historical Period

2018-2020

Unit

Value (USD billion)

Segmentation

By Level Of Care, Application, Age Group, Service Provider, and Geography

By Level of Care

  • Early Intervention
  • Level 1/Outpatient Services
  • Level 2
    • Intensive Outpatient Services
    • Partial Hospitalization Services
  • Level 3
    • Clinically Managed Low-Intensity Residential Services
    • Clinically Managed Medium-Intensity Residential Services
    • Clinically Managed High-Intensity Residential Services
    • Medically Monitored High-Intensity Inpatient Services
  • Level 4/Medically Managed Intensive Inpatient Services

By Application

  • Alcohol Addiction Treatment
  • Drug Abuse Treatment
  • Nicotine Addiction Treatment
  • Opioid Addiction Treatment

By Age Group

  • Adult
  • Adolescent

By Service Provider

  • Rehabilitation Centers
  • Hospitals and Specialty Clinics
  • Sober Living Homes
  • Others

By Geography

  • Northeast
  • West
  • South
  • Midwest
  • Other U.S. Territories
  • 2018-2029
  • 2021
  • 2018-2020
  • 81
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann